Loading

Setting the Record Straight

  • by NORML October 23, 2017

    HumboldtOne of NORML’s primary missions is to move public opinion sufficiently to legalize the responsible use of marijuana by adults. One of the ways we successfully achieve this goal is by debunking marijuana myths and half-truths via the publication of timely op-eds in online and print media. Since the mainstream media seldom casts a critical eye toward many of the more over-the-top claims about cannabis, we take it upon ourselves to set the record straight.

    The majority of NORML’s rebuttals are penned by Deputy Director Paul Armentano. In the past few weeks, he has published numerous op-eds rebuking a litany of popular, but altogether specious claims about the cannabis plant – including the contentions that cannabis consumption is linked to poor health outcomes, problems with regulations, and the effects of opioid abuse, hospitalizations, and fatalities in the states that have robust medical marijuana programs.

    Below are links to a sampling of his recent columns:

    Trump’s opioid agency fails to cite marijuana’s benefits, despite mounting evidence
    The Hill, October 23, 2017

    This is how legal cannabis is improving public health
    National Memo, October 22, 2017

    RMHIDTA’s marijuana reports are nothing but propaganda
    Denver Westword, October 21, 2017

    Marijuana is now a driving engine of the American economy
    Alternet, September 28, 2017

    When will our govt stop ignoring that marijuana is a major regulation success story
    Alternet, September 19, 2017

    Blowing up the big marijuana IQ myth — The science points to zero effect on your smarts
    The National Memo, August 7, 2017

    For a broader sampling of NORML-centric columns and media hits, please visit NORML’s ‘In the Media’ archive here.

    If you see the importance of NORML’s educational and media outreach efforts, please feel free to show your support by making a contribution here.

    6 Responses to “Setting the Record Straight”

    1. Julian says:

      That last article on The Hill along with one on Westward educating people about how our tax dollars get spent to deny the medical efficacy of schedule 1 drugs like marijuana is the damnifying evidence of an epic mass murder trial.

      And trials against marijuana prohibition there are:

      Things are heating up in the Washington v. Sessions case:

      https://www.pacermonitor.com/public/case/22047318/Washington_et_al_v_Sessions_et_al#

      The plaintiffs, including 11 year old Alexis Bortelli who is a Texan marijuana refugee who uses marijuana to stop her seizures have until the third of November to stop a Motion to Dismiss filed by Sessions.

      Anyone in contact with the plaintiff’s attorneys, Bondy, Holland or Hiller?

      The Plaintiff’s need to file a Second Amended Complaint using the studies on opiates like the JAMA report stating that the mandate in the CSAct that uses our tax dollars to deny the medical efficacy of schedule 1 drugs like marijuana, its extracts (or even kratom for that matter) that reduce opioid addiction and suicide reflect damages of “irreparable harm” to American society (and the plaintiffs) that not only justify injunctive relief, but demonstrate the unconstitutionality of the scheduling system by placing opioids in a lower scheduling than cannabis.

      The focus of this lawsuit has to be on the damages caused from the unconstitutional legislative authority of the CSAct to allow the defendants in the executive to write a toxic drug scheduling system. To show the damages expose the profit. Drag the Sacklers into this lawsuit.

    2. Julian says:

      Recent decisions based on state legislative action on mj favoring employees who consume medical marijuana off the job like Barbuto v. Advantage Sales & Marketing need to be cited in the Second Amended Answer for the Plaintiffs in the Washington v. Sessions case. It’s vitally important that cases that cite legislatively enacted marijuana legalization, even if only based on amendments, is cited in the argument to award damages in the form of injunctive relief.
      That is… mj scheduling frozen indefinetely until the defendents in the case (AG Sessions, DEA) can show a burden of proof that:
      A) Whether marijuana is not scientifically and medically benefiting the plaintiffs through state legislation And
      B) Whether the federal executive or legislative scheduling of whole plant remedies to opiate addiction and resulting suicides and overdose is constitutional.

      When I say “Drag the Sacklers in” to this case I mean subpeona them personally as well as Purdue Pharmaceuticals (separately) in order to build a case showing their timely connection to profits on oxycontin not only after the Marino bill was passed but also any direct lobbying that occurred between Purdue, the Sacklers and the DEA to maintain mj scheduling. Remember it’s the DOJ’s lawyers on the defense: they may have our tax dollars hostage but Purdue took all the DEA’s best lawyers. Joining them in this case (DEA & Purdue) is risky but those hirings are further evidence of the direct profiteering and lobbying by the Sacklers to maintain any herbal remedy for opiate addiction in the catch-22 of the unconstitutional schedule 1 listing.

      On the merits, the federal scheduling of marijuana in the 1 category that uses our tax dollars to deny its medical efficacy as it is engaged in state legislatively enacted law (Bv.ASM) is a violation of the 1st, 4th and 10th amendments, is causing “irreperable damage” and therefore qualifies for injunctive relief of the scheduling of marijuana.

      • mexweed says:

        In line 18-19 “lobbying by the Sacklers to maintain any herbal remedy for opiate addiction” I think you mean “suppress any herbal remedy”?

        • Julian says:

          It’s long-winded legalese but you have to finish the sentence… “…lobbying by the Sacklers to maintain any herbal remedy for opiate addiction (with)in the catch -22 of the schedule 1 listing.”

          There’s a money trail between the Sacklers and the DEA out there that placed marijuana extracts and kratom onto the schedule 1 listing in January of this year. It will require lots of money and a federal subpeona to find it.

          • mexweed says:

            o.k., thought I’d share that Joe Heller wanted to title his book “Catch 18″ but someone reminded him Leon Uris had used that number in “Mila 18″ so he changed it to 22. Then Vonnegut finished off the cluster with “Slaughterhouse 5″.
            .
            Drug the Sacklerhouse in? Yes!!!!

    3. jason Barstow says:

      I believe that more medical marijuana seed’s should be available AND at a much lower price i.e.not @ $10.00 apiece.right? thanks!

    Leave a Reply